A tertiary care audit of using abiraterone acetate in patients of metastatic castrate-resistant prostate cancer
{{output}}
Introduction: This is a retrospective analysis to assess the safety and efficacy of abiraterone acetate (AA) in metastatic castrate-resistant prostate cancer (mCRPC) patients treated at tertiary care institute. ... ...
